RaQualia Pharma

4579.TTSE GROWTHPharmaceutical
Financials · Standalone
Fiscal year ended2025-122024-122023-122022-122021-122020-12
Operating income¥691m¥323m−¥478m¥683m¥505m—
Ordinary income¥662m¥197m−¥445m¥701m¥656m−¥550m
Total assets¥11.0bn¥9.7bn¥6.6bn¥6.1bn¥5.2bn¥4.4bn
Net assets / equity¥7.4bn¥5.9bn¥5.9bn¥5.3bn¥4.8bn¥4.1bn
EPS (basic)¥21.06¥2.6¥-19.95¥27.83¥29.34¥-31.26

From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.

Reports · 6
PeriodFormFiledFigures
2023-01-01 → 2023-12-31AnnualAmended2024-06-14179 figures · EDINET
2023-01-01 → 2023-12-31Annual2024-03-27179 figures · EDINET
2023-01-01 → 2023-09-30Quarterly Q32023-11-1066 figures · EDINET
2023-01-01 → 2023-03-31Quarterly Q1Amended2023-09-0863 figures · EDINET
2023-01-01 → 2023-06-30Quarterly Q22023-08-1067 figures · EDINET
2023-01-01 → 2023-03-31Quarterly Q12023-05-1563 figures · EDINET

24 more reports are still being processed.